What was the market valuation of the China lip augmentation market in 2024?

The market valuation was $472.3 Million in 2024. Read More

What is the projected market valuation for the China lip augmentation market by 2035?

The projected market valuation is $1212.6 Million by 2035. Read More

What is the expected CAGR for the China lip augmentation market during the forecast period 2025 - 2035?

The expected CAGR is 8.95% during the forecast period 2025 - 2035. Read More

Which companies are considered key players in the China lip augmentation market?

Key players include Allergan, Revance Therapeutics, Medytox, Galderma, Ipsen, Hugel, and Sientra. Read More

What are the main types of procedures in the China lip augmentation market?

The main types of procedures include Injectable Fillers, Fat Grafting, and Implants. Read More

What was the market value for Injectable Fillers in 2024?

The market value for Injectable Fillers was between $200.0 Million and $500.0 Million in 2024. Read More

What materials are predominantly used in lip augmentation procedures?

Predominant materials include Hyaluronic Acid, Collagen, Silicone, Autologous Fat, and PMMA. Read More

What is the market value for Hyaluronic Acid in the China lip augmentation market?

The market value for Hyaluronic Acid ranged from $188.92 Million to $487.56 Million in 2024. Read More

What applications are driving the demand for lip augmentation in China?

Demand is driven by Cosmetic Enhancement, Reconstructive Surgery, and Medical Treatments. Read More

What are the primary end-use segments for lip augmentation procedures?

Primary end-use segments include Clinics, Hospitals, Beauty Salons, and Home Care. Read More

China Lip Augmentation Market

ID: MRFR/MED/52028-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

China Lip Augmentation Market Research Report By Type of Procedure (Injectable Fillers, Fat Grafting, Implants), By Material Used (Hyaluronic Acid, Collagen, Silicone, Autologous Fat, PMMA), By Application (Cosmetic Enhancement, Reconstructive Surgery, Medical Treatments) and By End Use (Clinics, Hospitals, Beauty Salons, Home Care) - Growth & Industry Forecast 2025 To 2035

China Lip Augmentation Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Type of Procedure (USD Million)
  1. 4.1.1 Injectable Fillers
  2. 4.1.2 Fat Grafting
  3. 4.1.3 Implants
2. 4.2 Construction, BY Material Used (USD Million)
  1. 4.2.1 Hyaluronic Acid
  2. 4.2.2 Collagen
  3. 4.2.3 Silicone
  4. 4.2.4 Autologous Fat
  5. 4.2.5 PMMA
3. 4.3 Construction, BY Application (USD Million)
  1. 4.3.1 Cosmetic Enhancement
  2. 4.3.2 Reconstructive Surgery
  3. 4.3.3 Medical Treatments
4. 4.4 Construction, BY End Use (USD Million)
  1. 4.4.1 Clinics
  2. 4.4.2 Hospitals
  3. 4.4.3 Beauty Salons
  4. 4.4.4 Home Care
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Allergan (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Revance Therapeutics (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medytox (KR)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Galderma (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Ipsen (FR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hugel (KR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Sientra (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Medytox (KR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY TYPE OF PROCEDURE
3. 6.3 CHINA MARKET ANALYSIS BY MATERIAL USED
4. 6.4 CHINA MARKET ANALYSIS BY APPLICATION
5. 6.5 CHINA MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CONSTRUCTION
9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
12. 6.12 CONSTRUCTION, BY TYPE OF PROCEDURE, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY TYPE OF PROCEDURE, 2024 TO 2035 (USD Million)
14. 6.14 CONSTRUCTION, BY MATERIAL USED, 2024 (% SHARE)
15. 6.15 CONSTRUCTION, BY MATERIAL USED, 2024 TO 2035 (USD Million)
16. 6.16 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
17. 6.17 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 CONSTRUCTION, BY END USE, 2024 (% SHARE)
19. 6.19 CONSTRUCTION, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Million)
  2. 7.2.2 BY MATERIAL USED, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China Construction Market Segmentation

Construction By Type of Procedure (USD Million, 2025-2035)

Injectable Fillers
Fat Grafting
Implants

Construction By Material Used (USD Million, 2025-2035)

Hyaluronic Acid
Collagen
Silicone
Autologous Fat
PMMA

Construction By Application (USD Million, 2025-2035)

Cosmetic Enhancement
Reconstructive Surgery
Medical Treatments

Construction By End Use (USD Million, 2025-2035)

Clinics
Hospitals
Beauty Salons
Home Care

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”